Centre Medico Chirurgical Ambroise Pare Hartmann — Clinical Trial Site

54 Registered trials

24 Currently recruiting

Organisation

Centre Medico Chirurgical Ambroise Pare Hartmann

Location

Neuilly-Sur-Seine, France

Identifier

ORG-100046315

Address

48 Ter Boulevard Victor Hugo, 92200, France

Departments

/
#6002: Intensive Care Unit
Cardiology
Centre satellite
Chirurgie cardiaque et interventionnelle
CLINIQUES AMBROISE PARE
FR10003: Institut des MICI
FR10008: Institut des MICI
Gastro-entérologie
GASTRO-ENTEROLOGIE ET HEPATOLOGIE
GASTROENTEROLOGIE
gastroenterology
Hépato-Gastro-Entérologie
Hepato-gastro-enterology
Institut des MICI
Intensive care
Intensive care medicine
lnstitut des MICI
maladies inflammatoires chroniques de l’intestin
Medical Oncology
Oncologie medicale
Oncology
Radiation Oncology
Réanimation
Service d’oncologie

Clinical trials at this site (54)

Search interface

PRODIGE 87 FOXTROT II : Personalising and refining neo-adjuvant chemotherapy in locally advanced but resectable colon cancer in the elderly … Recruiting

2023-505214-23-00 colon carcinoma 5 2024-06-07
Study of GS-5290 in Participants With Moderately to Severely Active Ulcerative Colitis Recruiting

2022-501119-14-01 Ulcerative Colitis 4 2024-04-16
Personalized, CT-guided antithrombotic therapy versus lifelong single antiplatelet therapy to reduce thromboembolic and bleeding events in n… Recruiting

2023-504637-42-01 aortic valve stenosis 6 2023-12-21
An open-label randomized trial COmparing staNdard of care versus Treat to target with telemonitoRing and patient education in patients with … Recruiting

2023-507256-76-00 Ulcerative colitis 6 2020-01-14
Prospective multicenter randomized controlled double-blind label study of the prophylaxis of recurrent pouchitis after fecal microbiota tran… Ended

2024-517078-52-00 Patients operated with an IPAA for ulcerative colitis w 5 2026-01-19
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008) Ended

2023-508636-61-00 Crohn’s Disease 5 2024-10-24
BOTAF - Prevention of post-operative Atrial Fibrillation by BOTulinum toxin injections into epicardial fat pads around pulmonary veins in pa… Ended

2024-513645-37-00 Adult patients with indication for conventional cardiac 5 2024-09-05
PRODIGE 85 (FFCD 1804) – KANALRAD Prospective randomized phase III study evaluating induction chemotherapy (modified DCF 4 cycles) followed… Ended

2023-505972-32-00 locally advanced anal squamous cell carcinoma 5 2024-02-26
Dose-finding study of SAR443122 in adult participants with ulcerative colitis Ended

2022-500290-14-01 Colitis ulcerative 4 2023-05-11
A Phase 3 Study to Evaluate the Efficacy and Safety of Guselkumab Subcutaneous Induction Therapy in Participants with Moderately to Severely… Ended

2023-504719-34-00 Moderate to Severly Active Ulcerative Colitis 5 2023-02-21
Efficacy and Safety of Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Crohn's Disease Ended

2023-504741-32-00 Moderately to Severely Active Crohn's Disease 4 2022-11-30
Efficacy and Safety of Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Ulcerative Colit… Ended

2023-504743-13-00 Moderately to Severely Active Ulcerative Colitis 4 2022-11-30
Management of moderate POstoperative recurrence in Crohn's disease: a randoMizEd contROLled trial of therapeutic escalation, the POMEROL tri… Ended

2023-508242-18-00 Crohn's disease 6 2021-12-21
Effects of ABX464 during long-term treatment in patients with moderate to severe ulcerative colitis Ended

2023-507974-42-00 Moderate to Severe Ulcerative Colitis 4 2021-12-01
Hydrocorticose and vasopressin in post-resuscitation syndrome Ended

2024-516373-77-00 Adult cardiac arrest patients with sustained ROSC and h 5 2021-07-18
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (M… Ended

2023-507188-21-00 Muscle-Invasive Urothelial Carcinoma (MIBC) of the Blad 5 2021-04-20
The USTAP CD trial USTekinumab in fistulising Perianal Crohn’s Disease: The USTAP CD study Ended

2023-503380-42-00 patient with moderate to severe Crohn's disease with at 6 2020-11-16
A Study to Assess the Efficacy and Safety of Risankizumab in Subjects with Ulcerative Colitis Ended

2023-506994-36-00 Ulcerative Colitis 5 2018-10-11
LUCENT-3 Extension Study of Mirikizumab in Ulcerative Colitis Ended

2023-507657-15-00 Ulcerative Colitis 5 2018-09-13
A Placebo controlled Maintenance and Long-term Extension Study of the Efficacy and Safety of Risankizumab in Participants with Crohn's Disea… Ended

2023-506399-28-00 Crohn's Disease 5 2017-11-08
PASSPORT Ended

2023-508584-72-00 Immune Bowel Disease (including Crohn's disease and Ulc 5 2024-07-10
Efficacy and Safety of JNJ-77242113 in Participants with Moderately to Severely Active Ulcerative Colitis Ended

2023-504673-20-00 Ulcerative Colitis 4 2023-12-06
Detection of tumor DNA in the blood of patients receiving standard therapy for hormone receptorpositive (HR+) non-HER2 expressing (HER2-) me… Ended

2022-502372-22-01 Metastatic Breast Cancer HR+, HER2- 4 2023-10-19
A single-arm, open-label study to evaluate the efficacy and safety of ABBV-668 in subjectswith moderate to severe ulcerative colitis Ended

2022-501263-41-00 Ulcerative Colitis 4 2023-08-10